Literature DB >> 3568976

Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients.

C Hsu.   

Abstract

A retrospective analysis of 5,255 pleural effusion specimens from 3,811 patients was undertaken to determine the accuracy of cytopathologic correlation with pleural biopsy, the detection rate of malignancy by cytology, and the frequency distribution of malignant effusions according to age group. The cytopathologic correlation was 96.5% accurate, with 0.1% false-positive results and 0.18% false-negative results by cytology. The sensitivity of cytologic detections was 6.7% higher than that of pleural biopsy. Frequency analysis showed that the incidence of carcinoma of the lung, the most common cause of malignant effusion, is not sex based. Adenocarcinoma of the lung was the most frequent type of malignancy found in pleural effusions. It represented 79% of lung carcinomas that metastasized to pleura, accounting for 40% of all malignant pleural effusions. In young adults, lymphoreticular malignancies were the most common cause of malignant effusions.

Entities:  

Mesh:

Year:  1987        PMID: 3568976     DOI: 10.1002/dc.2840030103

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  16 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation.

Authors:  Rogier A S Hoek; Stelios Gaitanakis; Merel E Hellemons
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 3.  Diagnostic tests in pleural effusion--an update.

Authors:  N Berkman; M R Kramer
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

Review 4.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Pleural effusion of malignant aetiology: cell block technique to establish the diagnosis.

Authors:  Rafael García Carretero; Manuela Manotas-Hidalgo; Marta Romero Brugera; Liliam El Bouayadi Mohamed
Journal:  BMJ Case Rep       Date:  2016-03-18

Review 6.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

7.  Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.

Authors:  Chaichana Chantharakhit; Nantapa Sujaritvanichpong
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

Review 8.  Management of malignant pleural effusion: challenges and solutions.

Authors:  Erika Penz; Kristina N Watt; Christopher A Hergott; Najib M Rahman; Ioannis Psallidas
Journal:  Cancer Manag Res       Date:  2017-06-23       Impact factor: 3.989

Review 9.  Contemporary best practice in the management of malignant pleural effusion.

Authors:  Coenraad F N Koegelenberg; Jane A Shaw; Elvis M Irusen; Y C Gary Lee
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

10.  Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.

Authors:  Nikolaos Barbetakis; Theodoros Antoniadis; Christodoulos Tsilikas
Journal:  World J Surg Oncol       Date:  2004-05-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.